Dec 2024
|
Axis Clinicals Limited
|
651,920
|
0.11%
|
0
|
0.00%
|
0
|
0.00%
|
Dec 2024
|
Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding)
|
16,572,131
|
2.85%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
Sep 2024
|
Axis Clinicals Limited
|
651,920
|
0.11%
|
0
|
0.00%
|
0
|
0.00%
|
Sep 2024
|
Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding)
|
16,572,131
|
2.85%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
Jun 2024
|
Axis Clinicals Limited
|
658,000
|
0.11%
|
658,000
|
100.00%
|
0
|
0.00%
|
Jun 2024
|
Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding)
|
16,726,716
|
2.85%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
Mar 2024
|
Axis Clinicals Limited
|
658,000
|
0.11%
|
658,000
|
100.00%
|
0
|
0.00%
|
Mar 2024
|
Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding)
|
16,726,716
|
2.85%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
Dec 2023
|
Axis Clinicals Limited
|
658,000
|
0.11%
|
658,000
|
100.00%
|
0
|
0.00%
|
Dec 2023
|
Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding)
|
16,726,716
|
2.85%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
Sep 2023
|
Axis Clinicals Limited
|
658,000
|
0.11%
|
658,000
|
100.00%
|
0
|
0.00%
|
Sep 2023
|
Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding)
|
16,726,716
|
2.85%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
Jun 2023
|
Axis Clinicals Limited
|
658,000
|
0.11%
|
658,000
|
100.00%
|
0
|
0.00%
|
Jun 2023
|
Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding)
|
16,726,716
|
2.85%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
Mar 2023
|
Axis Clinicals Limited
|
658,000
|
0.11%
|
658,000
|
100.00%
|
0
|
0.00%
|
Mar 2023
|
Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding)
|
16,726,716
|
2.85%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
Dec 2022
|
Axis Clinicals Limited
|
658,000
|
0.11%
|
658,000
|
100.00%
|
0
|
0.00%
|
Dec 2022
|
Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding)
|
16,726,716
|
2.85%
|
3,750,000
|
22.42%
|
0
|
0.00%
|
|
|
|
Sep 2022
|
Axis Clinicals Limited
|
658,000
|
0.11%
|
658,000
|
100.00%
|
0
|
0.00%
|
Sep 2022
|
Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding)
|
16,726,716
|
2.85%
|
3,750,000
|
22.42%
|
0
|
0.00%
|
|
|
|
Jun 2022
|
Axis Clinicals Limited
|
658,000
|
0.11%
|
658,000
|
100.00%
|
0
|
0.00%
|
Jun 2022
|
Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding)
|
16,726,716
|
2.85%
|
3,750,000
|
22.42%
|
0
|
0.00%
|
|
|
|
Mar 2022
|
Axis Clinicals Limited
|
658,000
|
0.11%
|
658,000
|
100.00%
|
0
|
0.00%
|
Mar 2022
|
Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding)
|
16,726,716
|
2.85%
|
3,750,000
|
22.42%
|
0
|
0.00%
|
|
|
|
Dec 2021
|
Axis Clinicals Limited
|
658,000
|
0.11%
|
658,000
|
100.00%
|
0
|
0.00%
|
Dec 2021
|
Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding)
|
16,726,716
|
2.85%
|
6,856,000
|
40.99%
|
0
|
0.00%
|
|
|
|
Sep 2021
|
Axis Clinicals Limited
|
658,000
|
0.11%
|
658,000
|
100.00%
|
0
|
0.00%
|
Sep 2021
|
Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding)
|
16,726,716
|
2.85%
|
6,970,000
|
41.67%
|
0
|
0.00%
|
|
|
|
Jun 2021
|
Axis Clinicals Limited
|
658,000
|
0.11%
|
658,000
|
100.00%
|
0
|
0.00%
|
Jun 2021
|
Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding)
|
16,726,716
|
2.85%
|
110,000
|
0.66%
|
0
|
0.00%
|
|
|
|
Mar 2021
|
Axis Clinicals Limited
|
658,000
|
0.11%
|
658,000
|
100.00%
|
0
|
0.00%
|
Mar 2021
|
Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding)
|
16,726,716
|
2.85%
|
3,710,000
|
22.18%
|
0
|
0.00%
|
|
|
|
Dec 2020
|
Axis Clinicals Limited
|
658,000
|
0.11%
|
658,000
|
100.00%
|
0
|
0.00%
|
Dec 2020
|
Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding)
|
16,726,716
|
2.85%
|
10,000
|
0.06%
|
0
|
0.00%
|
|
|
|
Sep 2020
|
Axis Clinicals Limited
|
658,000
|
0.11%
|
658,000
|
100.00%
|
0
|
0.00%
|
Sep 2020
|
Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding)
|
16,726,716
|
2.85%
|
3,100,000
|
18.53%
|
0
|
0.00%
|
|
|
|
Jun 2020
|
Axis Clinicals Limited
|
658,000
|
0.11%
|
658,000
|
100.00%
|
0
|
0.00%
|
Jun 2020
|
Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding)
|
16,726,716
|
2.85%
|
3,100,000
|
18.53%
|
0
|
0.00%
|
|
|
|
Mar 2020
|
Axis Clinicals Limited
|
658,000
|
0.11%
|
658,000
|
100.00%
|
0
|
0.00%
|
Mar 2020
|
Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding)
|
16,726,716
|
2.85%
|
3,100,000
|
18.53%
|
0
|
0.00%
|
|
|
|
Dec 2019
|
Axis Clinicals Limited
|
658,000
|
0.11%
|
658,000
|
100.00%
|
0
|
0.00%
|
Dec 2019
|
Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding)
|
16,726,716
|
2.85%
|
3,100,000
|
18.53%
|
0
|
0.00%
|
|
|
|
Sep 2019
|
Axis Clinicals Limited
|
658,000
|
0.11%
|
658,000
|
100.00%
|
0
|
0.00%
|
Sep 2019
|
Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding)
|
16,726,716
|
2.85%
|
3,100,000
|
18.53%
|
0
|
0.00%
|
|
|
|
Jun 2019
|
Axis Clinicals Limited
|
658,000
|
0.11%
|
658,000
|
100.00%
|
0
|
0.00%
|
Jun 2019
|
Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding)
|
16,726,716
|
2.85%
|
3,100,000
|
18.53%
|
0
|
0.00%
|
|
|
|
Mar 2019
|
Axis Clinicals Limited
|
658,000
|
0.11%
|
658,000
|
100.00%
|
0
|
0.00%
|
Mar 2019
|
Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding)
|
16,726,716
|
2.85%
|
3,100,000
|
18.53%
|
0
|
0.00%
|
|
|
|
Dec 2018
|
Axis Clinicals Limited
|
17,384,716
|
2.96%
|
658,000
|
100.00%
|
0
|
0.00%
|
|
|
|
Sep 2018
|
Axis Clinicals Limited
|
658,000
|
0.11%
|
658,000
|
100.00%
|
0
|
0.00%
|
Sep 2018
|
Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd (Jointly Holding)
|
16,726,716
|
2.85%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
Jun 2018
|
Axis Clinicals Limited
|
658,000
|
0.11%
|
658,000
|
100.00%
|
0
|
0.00%
|
Jun 2018
|
Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd (Jointly Holding)
|
16,726,716
|
2.85%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
Mar 2018
|
Axis Clinicals Limited Trident Chemphar Limited Rpr Sons Advisors Pvt.Ltd. (Jointly Holding)
|
16,426,716
|
2.80%
|
0
|
0.00%
|
0
|
0.00%
|
Mar 2018
|
Axis Clinicals Limited
|
658,000
|
0.11%
|
658,000
|
100.00%
|
0
|
0.00%
|
|
|
|
Dec 2017
|
Axis Clinicals Limited Trident Chemphar Limited Rpr Sons Advisors Pvt.Ltd. (Jointly Holding)
|
16,426,716
|
2.80%
|
0
|
0.00%
|
0
|
0.00%
|
Dec 2017
|
Axis Clinicals Limited
|
658,000
|
0.11%
|
658,000
|
100.00%
|
0
|
0.00%
|
|
|
|
Sep 2017
|
Axis Clinicals Limited
|
17,384,716
|
2.96%
|
658,000
|
100.00%
|
0
|
0.00%
|
|
|
|
Jun 2017
|
Axis Clinicals Limited Trident Chemphar Limited Rpr Sons Advisors Pvt.Ltd (Jointly Holding)
|
16,726,716
|
2.85%
|
0
|
0.00%
|
0
|
0.00%
|
Jun 2017
|
Axis Clinicals Limited
|
658,000
|
0.11%
|
658,000
|
100.00%
|
0
|
0.00%
|
|
|
|
Mar 2017
|
Axis Clinicals Limited Trident Chemphar Limited Rpr Sons Advisors Pvt.Ltd (Jointly Holding)
|
16,726,716
|
2.85%
|
0
|
0.00%
|
0
|
0.00%
|
Mar 2017
|
Axis Clinicals Limited
|
658,000
|
0.11%
|
658,000
|
100.00%
|
0
|
0.00%
|
|
|
|
Dec 2016
|
Axis Clinicals Limited
|
5,237,490
|
0.90%
|
1,058,000
|
20.20%
|
-
|
-%
|
|
|
|
Sep 2016
|
Axis Clinicals Limited
|
5,237,490
|
0.90%
|
1,058,000
|
20.20%
|
-
|
-%
|
|
|
|
Jun 2016
|
Axis Clinicals Limited
|
5,237,490
|
0.90%
|
1,058,000
|
20.20%
|
-
|
-%
|
|
|
|
Mar 2016
|
Axis Clinicals Limited
|
5,237,490
|
0.90%
|
1,058,000
|
20.20%
|
-
|
-%
|
|
|
|
Dec 2015
|
Axis Clinicals Ltd
|
5,237,490
|
0.90%
|
1,058,000
|
20.20%
|
-
|
-%
|